首页> 外文期刊>Gastroenterology research and practice >Bypass during Liver Transplantation: Anachronism or Revival? Liver Transplantation Using a Combined Venovenous/Portal Venous Bypass-Experiences with 163 Liver Transplants in a Newly Established Liver Transplantation Program
【24h】

Bypass during Liver Transplantation: Anachronism or Revival? Liver Transplantation Using a Combined Venovenous/Portal Venous Bypass-Experiences with 163 Liver Transplants in a Newly Established Liver Transplantation Program

机译:在肝移植过程中旁路:不间断的主义或复兴? 肝移植使用组合的静脉/门静脉旁路 - 在新建立的肝移植计划中具有163个肝脏移植的经验

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction. The venovenous/portal venous (VVP) bypass technique has generally become obsolete in liver transplantation (LT) today. We evaluated our experience with 163 consecutive LTs that used a VVP bypass. Patients and Methods. The liver transplant program was started in our center in 2010. LTs were performed using an extracorporal bypass device. Results. Mean operative time was 269 minutes and warm ischemic time 43 minutes. The median number of transfusion of packed cells and plasma was 7 and 14. There was no intraoperative death, and the 30-day mortality was 3%. Severe bypass-induced complications did not occur. Discussion. The introduction of a new LT program requires maximum safety measures for all of the parties involved. Both surgical and anaesthesiological management (reperfusion) can be controlled very reliably using a VVP bypass device. Particularly when using marginal grafts, this approach helps to minimise both surgical and anaesthesiological complications in terms of less volume overload, less use of vasopressive drugs, less myocardial injury, and better peripheral blood circulation. Conclusion. Based on our experiences while establishing a new liver transplantation program, we advocate the reappraisal of the extracorporeal VVP bypass.
机译:介绍。静脉/门静脉(VVP)旁路技术通常在今天肝移植(LT)过时。我们评估了我们使用VVP旁路的163个连续LTS的体验。患者和方法。肝脏移植计划于2010年开始于我们的中心。使用Extroplorporal旁路装置进行LTS。结果。平均手术时间为269分钟,温暖的缺血时间43分钟。包装细胞和血浆的中位数的输血次数为7和14.没有术中死亡,30天死亡率为3%。严重的旁路诱导的并发症没有发生。讨论。引入新的LT程序需要所有涉及的各方的最大安全措施。可以使用VVP旁路装置非常可靠地控制外科和麻醉学管理(再灌注)。特别是当使用边缘移植物时,这种方法有助于在较小的体积过载,较少使用血管加压药物,较少的心肌损伤和更好的外周血循环方面最小化手术和麻醉学并发症。结论。根据我们在建立新的肝移植计划的同时,我们倡导重新评估体外VVP旁路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号